The tweet was deleted by the author.
But we saved everything 🙂.
Eastman Kodak announced the launch of its new regulated pharmaceutical products, produced domestically at its cGMP facility in Rochester, New York.
By manufacturing these products in the U.S., the company aims to eliminate import tariffs and avoid overseas shipping delays, strengthening its service to domestic customers. The move is part of Eastman Kodak's broader strategy to enhance its position in pharmaceutical manufacturing and reinforce local supply chains.
Kodak has recently moved to deploy its expertise in chemicals and coatings to drive growth in battery and pharmaceutical sectors, according to a previous announcement about its business expansion. The company has also extended its global supply chain operations, focusing on reliability in delivering film, printing plates and advanced materials to international customers. These steps align with Kodak’s ongoing push into advanced manufacturing.